Meeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: 4019 Authors: Ghassan K. Abou-Alfa, Tim Meyer, Ann-Lii Cheng, et. al. Background: C, an inhibitor of MET, VEGFR, and AXL, has previously shown clinical activity in pts with advanced HCC. This phase 3 trial (NCT01908426) evaluated C vs P in...
Pro zobrazení tohoto obsahu je třeba být přihlášen.